GILEAD SCIENCES INC (GILD:NASDAQ)
$138.55 -1.22 (-0.8729%)
Analysed GILEAD SCIENCES INC (GILD:NASDAQ) News Sources
Gauging Gilead Sciences (GILD) Valuation After Strong Multi‑Year Shareholder Returns
16-04-2026
yahoo.com
Sector Update: Health Care Stocks Decline Late Afternoon
16-04-2026
yahoo.com
Tempus AI Expands Strategic Partnership Amid Oncology Boom
16-04-2026
yahoo.com
Gilead Sciences' HIV Drug Shows Weaker-Than-Expected Persistence Nine Months After Launch, RBC Says
16-04-2026
yahoo.com
Danaher Gears Up to Post Q1 Earnings: What Lies Ahead for the Stock?
16-04-2026
yahoo.com
Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It
16-04-2026
yahoo.com
Will Breyanzi's Strong Uptake Help BMY Offset Generic Competition?
15-04-2026
yahoo.com
Here's Why Gilead Sciences (GILD) Gained But Lagged the Market Today
14-04-2026
yahoo.com
PEPFAR and The Global Fund Make Additional Investment in Gilead’s Lenacapavir for HIV Prevention to Further Expand Access
14-04-2026
yahoo.com
Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names
14-04-2026
yahoo.com
What is the current price of GILEAD SCIENCES INC (GILD:NASDAQ)?
The current price of GILEAD SCIENCES INC (GILD:NASDAQ) is $138.55.
GILEAD SCIENCES INC (GILD:NASDAQ) absolute price change since previous trading day?
The absolute price change of GILEAD SCIENCES INC (GILD:NASDAQ) since the previous trading day is $-1.22.
GILEAD SCIENCES INC (GILD:NASDAQ) percentage price change since previous trading day?
The percentage price change of GILEAD SCIENCES INC (GILD:NASDAQ) since the previous trading day is -0.8729%.
What is the most recent average sentiment score for GILEAD SCIENCES INC (GILD:NASDAQ)?
The most recent average sentiment score for GILEAD SCIENCES INC (GILD:NASDAQ) is 72 out of 100.
What is the most recent average sentiment for GILEAD SCIENCES INC (GILD:NASDAQ)?
The most recent sentiment for GILEAD SCIENCES INC (GILD:NASDAQ) is .
SEC-8K** Filing Available For GILEAD SCIENCES INC (GILD:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.